文献速递乳腺癌

FAST试验十年结果:早期乳腺癌5次全乳放疗随机对照研究

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.
PubMed 文献 · J Clin Oncol · 2020-07-14

FAST试验纳入915例≥50岁低危浸润性乳腺癌患者,随机接受50 Gy/25次或30 Gy/5次或28.5 Gy/5次全乳放疗。十年结果显示28.5 Gy/5次与50 Gy/25次正常组织效应无显著差异,而30 Gy/5次正常组织效应更高,局部肿瘤控制无显著差异。

要点

  • 28.5 Gy/5次每周一次与50 Gy/25次相比,10年正常组织效应无显著差异。
  • 30 Gy/5次每周一次与50 Gy/25次相比,正常组织效应显著增高。
  • 三组同侧乳腺癌事件和死亡数无显著差异。

核心结论

  • 10年时,28.5 Gy/5次与50 Gy/25次相比正常组织效应率无显著差异,但30 Gy/5次正常组织效应更高。
  • 每周一次5次全乳放疗方案在放射生物学上可与常规分割方案相当。

研究设计与样本

  • 随机对照试验,2004-2007年从18个英国中心招募915例≥50岁低危浸润性乳腺癌(pT1-2 pN0)女性。
  • 随机分配至50 Gy/25次(5周)或30 Gy/5次(每周一次6.0 Gy)或28.5 Gy/5次(每周一次5.7 Gy)。
  • 主要终点为2年和5年乳房照片外观变化;次要终点为医生评估的正常组织效应和局部肿瘤控制。

主要发现

  • 5年照片可评估615/862(71%)合格患者。
  • 照片终点α/β估计值为2.7 Gy(95% CI 1.5-3.9 Gy),5次方案28 Gy(95% CI 26-30 Gy)估计与50 Gy/25次等效。
  • 中位随访9.9年,同侧乳腺癌事件11例(50 Gy:3;30 Gy:4;28.5 Gy:4),死亡96例(50 Gy:30;30 Gy:33;28.5 Gy:33)。

临床怎么用

  • 对于≥50岁低危早期乳腺癌患者,每周一次28.5 Gy/5次全乳放疗可作为与50 Gy/25次正常组织效应相当的方案选择。
  • 30 Gy/5次方案正常组织效应较高,临床选择时需权衡。

局限性

  • 5年照片仅71%合格患者可评估。
  • 随访期内同侧乳腺癌事件和死亡数较少,局部肿瘤控制比较的统计效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Previous studies of hypofractionated adjuvant whole-breast radiotherapy for early breast cancer established a 15- or 16-fraction (fr) regimen as standard. The FAST Trial (CRUKE/04/015) evaluated normal tissue effects (NTE) and disease outcomes after 5-fr regimens. Ten-year results are presented. METHODS: Women ≥ 50 years of age with low-risk invasive breast carcinoma (pT1-2 pN0) were randomly assigned to 50 Gy/25 fr (5 weeks) or 30 or 28.5 Gy in 5 once-weekly fr of 6.0 or 5.7 Gy. The primary end point was change in photographic breast appearance at 2 and 5 years; secondary end points were physician assessments of NTE and local tumor control. Odds ratios (ORs) from longitudinal analyses compared regimens. RESULTS: A total of 915 women were recruited from 18 UK centers (2004-2007). Five-year photographs were available for 615/862 (71%) eligible patients. ORs for change in photographic breast appearance were 1.64 (95% CI, 1.08 to 2.49; P = .019) for 30 Gy and 1.10 (95% CI, 0.70 to 1.71; P = .686) for 28.5 Gy versus 50 Gy. α/β estimate for photographic end point was 2.7 Gy (95% CI, 1.5 to 3.9 Gy), giving a 5-fr schedule of 28 Gy (95% CI, 26 to 30 Gy) estimated to be isoeffective with 50 Gy/25 fr. ORs for any moderate/marked physician-assessed breast NTE (shrinkage, induration, telangiectasia, edema) were 2.12 (95% CI, 1.55 to 2.89; P < .001) for 30 Gy and 1.22 (95% CI, 0.87 to 1.72; P = .248) for 28.5 Gy versus 50 Gy. With 9.9 years median follow-up, 11 ipsilateral breast cancer events (50 Gy: 3; 30 Gy: 4; 28.5 Gy: 4) and 96 deaths (50 Gy: 30; 30 Gy: 33; 28.5 Gy: 33) have occurred. CONCLUSION: At 10 years, there was no significant difference in NTE rates after 28.5 Gy/5 fr compared with 50 Gy/25 fr, but NTE were higher after 30 Gy/5 fr. Results confirm the published 3-year findings that a once-weekly 5-fr schedule of whole-breast radiotherapy can be identified that appears to be radiobiologically comparable for NTE to a conventionally fractionated regimen.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Brunt AM, Haviland JS, Sydenham M, et al. Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer. J Clin Oncol. 2020. PMID: 32663119. doi:10.1200/JCO.19.02750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。